Literature DB >> 24358891

Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts.

Toshihiro Masaki1, Aidan McGlinchey2, Simon R Tomlinson2, Jinrong Qu3, Anura Rambukkana4.   

Abstract

BACKGROUND: Bacterial pathogens can manipulate or subvert host tissue cells to their advantage at different stages during infection, from initial colonization in primary host niches to dissemination. Recently, we have shown that Mycobacterium leprae (ML), the causative agent of human leprosy, reprogrammed its preferred host niche de-differentiated adult Schwann cells to progenitor/stem cell-like cells (pSLC) which appear to facilitate bacterial spread. Here, we studied how this cell fate change influences bacterial retention and transfer properties of Schwann cells before and after reprogramming.
RESULTS: Using primary fibroblasts as bacterial recipient cells, we showed that non-reprogrammed Schwann cells, which preserve all Schwann cell lineage and differentiation markers, possess high bacterial retention capacity when co-cultured with skin fibroblasts; Schwann cells failed to transfer bacteria to fibroblasts at higher numbers even after co-culture for 5 days. In contrast, pSLCs, which are derived from the same Schwann cells but have lost Schwann cell lineage markers due to reprogramming, efficiently transferred bacteria to fibroblasts within 24 hours.
CONCLUSIONS: ML-induced reprogramming converts lineage-committed Schwann cells with high bacterial retention capacity to a cell type with pSLC stage with effective bacterial transfer properties. We propose that such changes in cellular properties may be associated with the initial intracellular colonization, which requires long-term bacterial retention within Schwann cells, in order to spread the infection to other tissues, which entails efficient bacterial transfer capacity to cells like fibroblasts which are abundant in many tissues, thereby potentially maximizing bacterial dissemination. These data also suggest how pathogens could take advantage of multiple facets of host cell reprogramming according to their needs during infection.

Entities:  

Year:  2013        PMID: 24358891      PMCID: PMC3829123.1          DOI: 10.12688/f1000research.2-198.v1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  23 in total

1.  Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.

Authors:  J K Choi; N Hoang; A M Vilardi; P Conrad; S G Emerson; A M Gewirtz
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

2.  Leprosy: contribution of mast cells to epineurial collagenization.

Authors:  N Aparecida de Arantes Montagna; M Leide Wan-del-Rey de Oliveira; C A Mandarim-de-Lacerda; L Chimelli
Journal:  Clin Neuropathol       Date:  2005 Nov-Dec       Impact factor: 1.368

Review 3.  Endoneurial fibroblast-like cells.

Authors:  Laurence Richard; Piotr Topilko; Laurent Magy; Anne-Valérie Decouvelaere; Patrick Charnay; Benoît Funalot; Jean-Michel Vallat
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

4.  Massive gene decay in the leprosy bacillus.

Authors:  S T Cole; K Eiglmeier; J Parkhill; K D James; N R Thomson; P R Wheeler; N Honoré; T Garnier; C Churcher; D Harris; K Mungall; D Basham; D Brown; T Chillingworth; R Connor; R M Davies; K Devlin; S Duthoy; T Feltwell; A Fraser; N Hamlin; S Holroyd; T Hornsby; K Jagels; C Lacroix; J Maclean; S Moule; L Murphy; K Oliver; M A Quail; M A Rajandream; K M Rutherford; S Rutter; K Seeger; S Simon; M Simmonds; J Skelton; R Squares; S Squares; K Stevens; K Taylor; S Whitehead; J R Woodward; B G Barrell
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

Review 5.  The armadillo as a model for peripheral neuropathy in leprosy.

Authors:  Richard W Truman; Gigi J Ebenezer; Maria T Pena; Rahul Sharma; Gayathriy Balamayooran; Thomas H Gillingwater; David M Scollard; Justin C McArthur; Anura Rambukkana
Journal:  ILAR J       Date:  2014

6.  Viable M. leprae as a research reagent.

Authors:  R W Truman; J L Krahenbuhl
Journal:  Int J Lepr Other Mycobact Dis       Date:  2001-03

7.  Infection of mouse macrophages with viable Mycobacterium leprae does not induce apoptosis.

Authors:  Ramanuj Lahiri; Baljit Randhawa; James L Krahenbuhl
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

8.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

Review 9.  Looking within the zebrafish to understand the tuberculous granuloma.

Authors:  Lalita Ramakrishnan
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 10.  Negative regulation of myelination: relevance for development, injury, and demyelinating disease.

Authors:  Kristján R Jessen; Rhona Mirsky
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

View more
  3 in total

Review 1.  Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions.

Authors:  Samuel Hess; Anura Rambukkana
Journal:  Curr Opin Microbiol       Date:  2014-12-23       Impact factor: 7.934

Review 2.  Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System.

Authors:  Samuel Hess; Anura Rambukkana
Journal:  Microbiol Spectr       Date:  2019-07

Review 3.  Changing Stem Cell Dynamics during Papillomavirus Infection: Potential Roles for Cellular Plasticity in the Viral Lifecycle and Disease.

Authors:  Katerina Strati
Journal:  Viruses       Date:  2017-08-12       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.